Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

One-year Clinical Outcome of Topical Bromfenac in Central Serous Chorioretinopathy: Mi Sun Kwon, Yu Min Kim, Jin Young Kim, Jae Rock Do, Yong Koo Kang, Dong Ho Park; J Korean Ophthalmol Soc. 2024;65(7):435-441. Published online July 15, 2024; DOI: https://doi.org/10.3341/jkos.2024.65.7.435; Full text PubReader ePub PDF

Relationships Between Choroidal Characteristics and Disease Activity in Acute Central Serous Chorioretinopathy: Gyeongsoo Lim, Kyung Tae Kim, Eoi Jong Seo; J Korean Ophthalmol Soc. 2023;64(8):709-717. Published online August 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.8.709; Full text PubReader ePub PDF

Comparison of Intravitreal Bevacizumab and Aflibercept Injections for Central Serous Chorioretinopathy: Min Soo Park, Seung Joon Lee; J Korean Ophthalmol Soc. 2021;62(7):957-962. Published online July 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.7.957; Full text PubReader ePub PDF

Clinical Effects of Non-damaging Retinal Laser Therapy in Chronic Central Serous Chorioretinopathy: Ye Won Kim, Ki Woong Lee, Jong Ho Ahn, Dong Heun Nam, Dae Yeong Lee; J Korean Ophthalmol Soc. 2021;62(2):222-229. Published online February 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.2.222
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Therapeutic Effects and Safety of Spironolactone for Central Serous Chorioretinopathy: Jae Yong Han, Eun Young Choi, Christopher Seungkyu Lee; J Korean Ophthalmol Soc. 2020;61(11):1311-1321. Published online November 15, 2020; DOI: https://doi.org/10.3341/jkos.2020.61.11.1311
Web of Science 2 Crossref 2; Full text PubReader ePub PDF

Case Reports

Central Serous Chorioretinopathy Following High G-force Exposure in a Fighter Pilot: Byung Su Lim, Jae Yon Won; J Korean Ophthalmol Soc. 2020;61(6):690-693. Published online June 15, 2020; DOI: https://doi.org/10.3341/jkos.2020.61.6.690; Full text PubReader ePub PDF

Original Articles

Long-term Outcomes of and Recurrence Risk Factors Associated with Photodynamic Therapy to Treat Central Serous Chorioretinopathy: Suchan Lee, Mingui Kong, Joon Hong Sohn; J Korean Ophthalmol Soc. 2020;61(4):356-366. Published online April 15, 2020; DOI: https://doi.org/10.3341/jkos.2020.61.4.356; Full text PubReader ePub PDF

Is Central Serous Chorioretinopathy a Risk Factor for Neurocardiovascular Disease Development?: 10-year Nationwide Population-based Study: Seung Jae Lee, Jiwon Kim, Hyun Sun Lim, Eun Jee Chung; J Korean Ophthalmol Soc. 2020;61(4):347-355. Published online April 15, 2020; DOI: https://doi.org/10.3341/jkos.2020.61.4.347; Full text PubReader ePub PDF

Oral Spironolactone Treatment in Chronic Central Serous Chorioretinopathy.: Sae Rom Chung, Jin Gu Jeong, Tae Eun Lee, In Cheon You, Min Ahn, Nam Chun Cho; J Korean Ophthalmol Soc. 2020;61(3):250-257. Published online March 15, 2020; DOI: https://doi.org/10.3341/jkos.2020.61.3.250; PDF

Case Reports

Central Serous Chorioretinopathy with Peripapillary Retinoschisis.: Jong Heon Kim, Im Gyu Kim, Yong Il Kim, Kyoo Won Lee, Hyun Gu Kang; J Korean Ophthalmol Soc. 2019;60(6):587-593. Published online June 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.6.587; PDF

Original Articles

Clinical Presentations of Focal Choroidal Excavation and Results of Long-term Follow-up.: Seok Hyun Lee, Jae Hui Kim, Jong Woo Kim et al.; J Korean Ophthalmol Soc. 2019;60(6):541-546. Published online June 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.6.541
Web of Science 1 Crossref 5; PDF

Selective Retina Therapy in Patients with Central Serous Chorioretinopathy.: Jae Min Kim, Joo Yeon Kim; J Korean Ophthalmol Soc. 2018;59(10):915-921. Published online October 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.10.915; PDF

Comparison of Short-term Clinical Outcomes between Oral Spironolactone and Observation in Acute Central Serous Chorioretinopathy.: Jong Young Lee, Dong Yoon Kim, Eun Kyoung Lee et al.; J Korean Ophthalmol Soc. 2018;59(6):511-518. Published online June 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.6.511
Crossref 4; PDF

Clinical Manifestations of Steroid-associated Central Serous Chorioretinopathy.: Sung Won Choi, Yu Cheol Kim; J Korean Ophthalmol Soc. 2018;59(4):338-346. Published online April 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.4.338; PDF

Case Reports

A Case of Central Serous Chorioretinopathy after Tadalafil Treatment.: Yo Sep Yoon, Seunghwan Lee, Je Moon Woo, Jung Kee Min; J Korean Ophthalmol Soc. 2018;59(1):93-97. Published online January 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.1.93
Crossref 2; PDF

Volume 65, No. 11

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

Impact Factor

0.1

MOST VIEWED MOST CITED

6,871	Contact Lens-induced Acute Red Eye
1,508	Clinical Changes and Autoantibody Level Changes in Thyroid Eye Disease Patients after Intravenous High-dose Steroid therapy
1,112	Changes in Astigmatism after Surgery in Pediatric Patients with Limbal Dermoid
1,353	Self-assessment of Visual Acuity Using a Smartphone Application
1,069	Three Familial Cases of Stickler Syndrome: A Case Report

Cited By 3	Impact of Social Distancing and Personal Hygiene on the Prevalence of Epidemic Keratoconjunctivitis during the COVID-19 Pandemic
Cited By 3	Clinical Results of Cataract Surgery Using the ARTIS ® PL E Intraocular Lens
Cited By 3	Efficacy of Low-dose Atropine Eyedrops in Myopic Progression in Elementary School Children
Cited By 2	Comparison of Anterior Segment Measurements between Scheimpflug-Placido Camera and New Swept-source Optical Coherence Tomography
Cited By 2	Interocular Difference of Axial Length, Anterior Chamber Depth, Keratometry, Corneal Astigmatism According to Axial Length

Editorial Office: #1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6603 Fax: +82-2-2277-5194 E-mail: kos@ijpnc.com

Copyright © 2024 by Korean Ophthalmological Society.

prev

next